Sale!

SCN4A Gene Potassium-Aggravated Myotonia Genetic Test

Original price was: $700.Current price is: $500.

-29%

The SCN4A Gene Potassium-Aggravated Myotonia NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the SCN4A gene responsible for potassium-aggravated myotonia, a rare neurological disorder characterized by muscle stiffness and delayed relaxation. Using next-generation sequencing technology, this test provides comprehensive analysis of the sodium channel gene to help diagnose individuals experiencing muscle cramping, stiffness, and weakness triggered by potassium intake. The test costs $500 USD and is essential for patients with symptoms of myotonia, family history of muscle disorders, or unexplained muscle stiffness. Results help guide treatment decisions, inform genetic counseling, and provide clarity for family planning. Early diagnosis through this test can significantly improve quality of life by enabling targeted therapies and management strategies.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

SCN4A Gene Potassium-Aggravated Myotonia NGS Genetic DNA Test

Comprehensive Genetic Testing for Neurological Muscle Disorders

The SCN4A Gene Potassium-Aggravated Myotonia NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics, offering precise identification of mutations responsible for potassium-aggravated myotonia. This advanced testing methodology utilizes next-generation sequencing technology to analyze the SCN4A gene, which encodes the alpha subunit of the skeletal muscle sodium channel. Understanding these genetic variations is crucial for accurate diagnosis and effective management of this rare neuromuscular condition.

What This Test Measures and Detects

Our comprehensive genetic analysis specifically targets the SCN4A gene to identify pathogenic variants associated with potassium-aggravated myotonia. The test examines:

  • Point mutations in the SCN4A gene coding regions
  • Small insertions and deletions affecting sodium channel function
  • Genetic variations that alter muscle membrane excitability
  • Specific mutations known to cause delayed muscle relaxation
  • Variants that increase sensitivity to potassium levels

The NGS technology employed provides high-resolution analysis of the entire coding sequence, ensuring comprehensive coverage of potential mutation sites that could contribute to the development of myotonic symptoms.

Who Should Consider This Genetic Test

This specialized genetic test is recommended for individuals experiencing:

  • Muscle stiffness and delayed relaxation after movement
  • Muscle cramping triggered by potassium-rich foods
  • Difficulty releasing handgrip or eye closure
  • Family history of muscle disorders or myotonia
  • Unexplained muscle weakness or stiffness
  • Worsening symptoms with cold exposure
  • Muscle symptoms that improve with repeated activity (warm-up phenomenon)

Patients with suspected sodium channel myotonias or those with atypical presentations of muscle stiffness should strongly consider this diagnostic evaluation.

Key Benefits of SCN4A Genetic Testing

Undergoing this comprehensive genetic analysis provides numerous advantages:

  • Accurate Diagnosis: Confirms or rules out potassium-aggravated myotonia with high precision
  • Personalized Treatment: Enables targeted therapeutic approaches based on genetic findings
  • Family Planning Guidance: Provides essential information for genetic counseling and reproductive decisions
  • Symptom Management: Helps develop effective strategies for managing muscle stiffness and weakness
  • Early Intervention: Facilitates timely treatment initiation to prevent symptom progression
  • Genetic Risk Assessment: Identifies inheritance patterns for family members

Understanding Your Test Results

Our comprehensive genetic report provides clear interpretation of your results:

  • Positive Result: Indicates the presence of a pathogenic SCN4A mutation associated with potassium-aggravated myotonia. This confirms the diagnosis and guides specific treatment recommendations.
  • Negative Result: Suggests that no known pathogenic mutations were detected in the SCN4A gene. However, clinical correlation remains important as other genetic or non-genetic factors may contribute to symptoms.
  • Variant of Uncertain Significance: Some genetic changes may have unclear clinical implications. These require ongoing monitoring and may be reclassified as more research becomes available.

All results are accompanied by detailed explanations and recommendations for next steps, including consultation with our genetic specialists for comprehensive interpretation.

Test Pricing and Availability

Test Name Discount Price Regular Price
SCN4A Gene Potassium-Aggravated Myotonia NGS Genetic DNA Test $500 USD $700 USD

Nationwide Testing Availability

We provide comprehensive genetic testing services across the United States with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our network of certified collection centers ensures accessible testing for patients nationwide.

Take the Next Step Toward Diagnosis

If you or a loved one are experiencing symptoms of muscle stiffness, delayed relaxation, or have a family history of neuromuscular disorders, don’t wait to get answers. Our SCN4A Gene Potassium-Aggravated Myotonia NGS Genetic DNA Test provides the clarity needed for proper diagnosis and treatment planning.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic test consultation and take control of your neurological health.

Our team of genetic counselors and neurological specialists are ready to guide you through the testing process, from pre-test counseling to comprehensive result interpretation and personalized management recommendations.